Altria Reports 2025 Results with $2.1B E-Vapor Impairment, NJOY ACE Ban; Raises Dividend

summarizeSummary

Altria Group reported its 2025 financial results, including a significant $2.1 billion non-cash impairment charge related to its e-vapor segment following an ITC exclusion order on NJOY ACE, while also announcing a dividend increase and an expanded share repurchase program.

check_boxKey Events

• Significant E-Vapor Segment Impairment

  Altria recorded a total of $2.128 billion in non-cash impairment charges for its e-vapor reporting unit in 2025, comprising $1.158 billion in goodwill and $970 million in definite-lived intangible assets.

• NJOY ACE Import and Sale Ban

  The U.S. International Trade Commission (ITC) issued an exclusion order and cease-and-desist orders, effective March 31, 2025, prohibiting the importation and sale of NJOY ACE in the United States.

• Decline in Financial Performance

  Net earnings for 2025 decreased to $6,947 million ($4.12 EPS) from $11,264 million ($6.54 EPS) in 2024.

• Dividend Increase and Share Repurchase Program

  The Board approved a 3.9% increase in the quarterly dividend to $1.06 per share (annualized $4.24) and expanded the share repurchase program to $2.0 billion.

auto_awesomeAnalysis

This filing reveals a challenging year for Altria, primarily driven by significant setbacks in its strategic e-vapor segment. The $2.1 billion impairment charge and the ITC's ban on NJOY ACE sales in the U.S. fundamentally alter the growth trajectory and profitability expectations for Altria's investment in the e-vapor market. This regulatory action and the subsequent re-evaluation of the e-vapor market's enforcement environment against illicit products led to a substantial write-down of goodwill and intangible assets. The sharp decline in net earnings and EPS further underscores these operational difficulties. Despite these significant headwinds, the company's decision to increase its dividend and expand its share repurchase program signals management's confidence in the underlying strength of its traditional tobacco businesses and its commitment to shareholder returns. Investors should monitor the ongoing legal challenges and the company's strategy for its e-vapor portfolio, as well as the impact of the adverse tax ruling.